Muh-Hwan Su
- 2Articles
- 7.7KReads1
- 2000Active
- 8Collaborators
About
Muh-Hwan Su has published research focused on the pharmacological treatment of schizophrenia and schizoaffective disorders. The work includes studies on dosing strategies and plasma levels of risperidone in acute schizophrenia exacerbations, as well as the impact of fluvoxamine on reducing clozapine dosage in refractory cases. Su's publications appeared in 2000 in Psychiatrist.com (The Journal of Clinical Psychiatry and The Primary Care Companion for CNS Disorders). Frequent collaborators include Hsien-Yuan Lane, Wen-Ho Chang, Kun-Po Chen, Michael W. Jann, and Mong-Liang Lu.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
